A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
Clinical trial NCT04032197 · COMPLETED
Trial details
- NCT number
- NCT04032197
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2022-12-16
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.